Iqvia Holdings (IQV) Accumulated Expenses (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Accumulated Expenses came in at $3.6 billion in Q2 2026, up 6.15% year-over-year from $3.4 billion in Q2 2025, and down 0.85% quarter-over-quarter from $3.6 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Accumulated Expenses (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Accumulated Expenses across 15 years of filings, most recently posting $3.6 billion for Q2 2026.
- In Q2 2026, Accumulated Expenses rose 6.15% year-over-year to $3.6 billion; the TTM figure through Jun 2026 stood at $3.6 billion (up 6.15% YoY), while the FY2025 annual figure was $3.8 billion, up 1.82% from the prior year.
- Accumulated Expenses came in at $3.6 billion for Q2 2026 at Iqvia Holdings, down from $3.6 billion in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $3.8 billion in Q4 2025 to a low of $2.8 billion in Q1 2022.
- Average Accumulated Expenses over 5 years is $3.3 billion, with a median of $3.4 billion recorded in 2024.
- Year-over-year, Accumulated Expenses retreated 0.11% in 2022 and grew 11.61% in 2023.
- Over 5 years, Accumulated Expenses stood at $3.3 billion in 2022, then grew by 7.48% to $3.6 billion in 2023, then increased by 3.37% to $3.7 billion in 2024, then increased by 1.82% to $3.8 billion in 2025, then retreated by 3.81% to $3.6 billion in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $3.6 billion in Q2 2026, $3.6 billion in Q1 2026, and $3.8 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.61 Bn |
| Mar 31, 2026 | 3.64 Bn |
| Dec 31, 2025 | 3.75 Bn |
| Sep 30, 2025 | 3.55 Bn |
| Jun 30, 2025 | 3.40 Bn |
| Mar 31, 2025 | 3.56 Bn |
| Dec 31, 2024 | 3.68 Bn |
| Sep 30, 2024 | 3.43 Bn |
| Jun 30, 2024 | 3.31 Bn |
| Mar 31, 2024 | 3.46 Bn |
| Dec 31, 2023 | 3.56 Bn |
| Sep 30, 2023 | 3.13 Bn |
| Jun 30, 2023 | 3.01 Bn |
| Mar 31, 2023 | 3.14 Bn |
| Dec 31, 2022 | 3.32 Bn |
| Sep 30, 2022 | 2.97 Bn |
| Jun 30, 2022 | 2.85 Bn |
| Mar 31, 2022 | 2.82 Bn |
| Dec 31, 2021 | 2.98 Bn |
| Sep 30, 2021 | 2.66 Bn |